Popular obesity stocks fell on Tuesday after pharma giant Eli Lilly LLY lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. LLY’s ...

We recently compiled a list of the 14 Best 52-Week High Stocks To Buy According to Analysts. In this article, we are going to ...

The company, which works with pharma, cosmetics and healthcare companies had outgrown its existing space in Steele Creek.

Michelle Greene leads with emphathy. She believes that has been her secret sauce in forging productive bonds across her ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

A new study of hemp microbes may lead to more sustainable farming methods, using nature to boost the growth of the plant which has become increasingly popular for its versatile uses: CBD-rich ...

"Eli Lilly Cuts 4Q Sales Outlook After Sluggish Growth for Incretin Drugs," published at 10:06 a.m. ET, incorrectly said the outlook was around $400 below the low end of its last estimated range ...

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

BridgeBio Pharma also said it expects $105 million in regulatory milestones from acoramidis - sold under the brand name Attruby - approvals in Europe and Japan in the first half of the year, and that ...

IGC Pharma, Inc (NYSE American:IGC) (”IGC” or the “Company”), today announced that CEO Ram Mukunda and CCO Claudia Grimaldi ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...